Optimisation of Hydal technology on an industrial scale
Public support
Provider
Ministry of Industry and Trade
Programme
TRIO
Call for proposals
TRIO 1 (SMPO201600001)
Main participants
NAFIGATE Corporation, a.s.
Contest type
VS - Public tender
Contract ID
2016FV10326
Alternative language
Project name in Czech
Optimalizace technologie Hydal v průmyslovém měřítku
Annotation in Czech
Cílem projektu je: 1. Zvýšit produktivitu a efektivitu výzkumných aktivit NAFIGATE Corporation a.s. ve spolupráci s MBÚ AV ČR, v.v.i. 2. Optimalizací biotechnologie Hydal posílit udržitelnost rozvoje ekonomiky - biotechnologie jako zdroj používá ze 100% odpad /použitý fritovací olej/, který nemá žádné další využití a zároveň je energeticky nezávislá s nulovou karbonovou stopou. 3. Posílit konkurenceschopnost českého hospodářství - nabídka a využití této české biotechnologie bude v globálním měřítku.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
CI - Industrial chemistry and chemical engineering
CEP - secondary branch
EI - Biotechnology and bionics
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20401 - Chemical engineering (plants, products)<br>20402 - Chemical process engineering<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
The project has achieved the set objectives and outputs of the project. The result of the project is the optimized Hydal biotechnology.
Solution timeline
Realization period - beginning
Aug 1, 2016
Realization period - end
Jul 31, 2018
Project status
U - Finished project
Latest support payment
Apr 23, 2018
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP19-MPO-FV-U
Data delivery date
Apr 15, 2024
Finance
Total approved costs
6,859 thou. CZK
Public financial support
5,337 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
1,521 thou. CZK